Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Alzheimer's Research UK
Headquarters: Cambridge, United Kingdom
Website: http://www.alzheimersresear...
Year Founded: 1993
Status: Non-biopharma
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Oct 14, 2023
Emerging Company Profile
AstronauTx: targeting astrocytes to treat neurodegenerative diseases
London, U.K.-based company aims to clear a wide array of toxic proteins out of the brain, and is settings it first sights on Alzheimer’s disease
BioCentury | Jun 20, 2022
Deals
U.K. partners to accelerate gene therapy development for dementia
CGT Catapult, UK DRI to work with academic centers to identify assets
BioCentury | Mar 14, 2020
Politics, Policy & Law
Patient access to new Alzheimer’s drugs will depend on diagnostic innovation and payment reform
With Biogen’s Alzheimer’s therapy up for approval this year, there’s an urgency to solve market access
BioCentury | Dec 5, 2018
Politics & Policy
U.K. unveils second life sciences deal, headlined by UCB investment
BioCentury | Oct 26, 2018
Company News
Dementia Discovery Fund, UK Dementia Research Institute partner to fund dementia research
BioCentury | Oct 24, 2018
Company News
Dementia Discovery Fund, UK Dementia Research Institute partner to fund dementia research
Items per page:
1 - 10 of 33